Skip to content

Evaluation of the effects of overhead infrared light irradiation in patients with Parkinson's disease

Evaluation of the effects of transcranial photobiomodulation in patients with Parkinson´s disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-72hp4v9
Enrollment
Unknown
Registered
2024-10-22
Start date
2024-09-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypokinesia

Interventions

This is a controlled, longitudinal, prospective, double-blind, randomized clinical trial, with the sample divided into two groups. The intervention group will consist of 36 patients diagnosed with Par
E02.774

Sponsors

Universidade Federal de Pernambuco
Lead Sponsor
Associação de Parkinson de Pernambuco
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: As inclusion criteria, volunteers of both genders who are patients diagnosed with Parkinson disease (PD) in stages I to III of the Hoehn and Yahr scale (Shenkman et al., 2001); they must be between 18 and 60 years old; volunteers of both sexes will be accepted; volunteers in the active period must present themselves without severe dyskinesia; they must be able to remain in an upright position, standing still for at least 2 minutes and walk without assistance for 10 meters; free from sensory changes in the head region or inability to communicate with the researcher in any type of eventuality such as emergency situations

Exclusion criteria

Exclusion criteria: As for exclusion criteria, participants must not present any neurological condition other than Parkinson disease (PD), such as Alzheimer's disease and other dementias; sequelae of stroke; cognitive insufficiency; delirium; depression; use deep brain stimulators or any other types of brain implants; patients will also be excluded if they have a history of head surgery; cranioplasty; metallic implants; stents; ventriculoperitoneal shunts; hydrocephalus; microcephaly; traumatic brain injury; myelomeningocele; meningocele and any other malformation of the central nervous system

Design outcomes

Primary

MeasureTime frame
This research is expected to improve the motor function of individuals in the intervention group, as well as improve cognitive function and other non-motor signs and symptoms.

Secondary

MeasureTime frame
No secondary outcomes are expected

Countries

Brazil

Contacts

Public ContactAlexandre da Silva

Universidade Federal de Pernambuco

alexandre.roques@ufpe.br+55(81) 997983531

Outcome results

None listed

Source: REBEC (via WHO ICTRP)